Paratus is decoding evolution to discover and develop first-in-class medicines for serious diseases where today’s therapies fall short. We integrate evolutionary biology, AI-powered discovery and deep multi-omic data to uncover biologically validated pathways that can inform new medicines. We are advancing PS-1001, a first-in-class pan-inflammasome inhibitor and our lead program, toward first-in-human studies, alongside a broader pipeline of differentiated therapeutic programs in cardiometabolic and immune and inflammatory diseases. We're headquartered in Boston, Mass., with research operations in Singapore.
| Website | https://www.paratussciences.com |
| Employees | 20 (16 on RocketReach) |
| Founded | 2021 |
| Industry | Biotechnology Research |
| Keywords | Molecular Biology, Drug Discovery, Translational Research, Biotechnology, Preclinical Research, Pharmaceutical Research, Novel Therapeutics, Disease Resistance, Life Sciences, Biomedical Research, Immunology Research, Animal Models, Genetic Research, Wildlife Biology, Conservation Biology |
| Competitors | Roche, Thermo Fisher Scientific, BD, Agilent Technologies, MilliporeSigma, PerkinElmer, Inc., Bio-Rad Laboratories, Waters Corporation, Bruker, Eppendorf Group +37 more (view full list) |
Looking for a particular Paratus Sciences employee's phone or email?
Paratus Sciences Questions
Alicia Secor is the President and CEO of Paratus Sciences.
16 people are employed at Paratus Sciences.
Paratus Sciences is based in Boston, Massachusetts.
Top Paratus Sciences Employees
-
Alicia Secor
President and CEO at Paratus Sciences
Boston, MA, US35 -
Mark Cockett
President and Chief Scientific Officer at Paratus Sciences
New Haven, CT, US45+ -
33
-
22
-
Yongin Choi
Machine learning scientist at Paratus Sciences
Boston, MA, US2
Related Companies
